CD44 Gene Polymorphisms in Breast Cancer Risk and Prognosis: A Study in North Indian Population

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Tulsyan, Sonam ^a   Agarwal, Gaurav ^a   Lal, Punita ^a   Agrawal, Sushma ^a   De Mittal, Ramavi ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ADULT; AGE; ALLELE; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RISK; CASE CONTROL STUDY; CD44 GENE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; TUMOR VOLUME;

EID: 84881095710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071073     Document Type: Article

References (38)

1. Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, et al. (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6: 391-401.
2. Peto J, Collins N, Barfoot R, Seal S, Warren W, et al. (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91: 943-949.
3. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer 83: 1301-1308.
4. Lobo NA, Shimono Y, Qian D, Clarke MF, (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699.
5. Goodfellow PN, Banting G, Wiles MV, Tunnacliffe A, Parkar M, et al. (1982) The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11. Eur J Immunol 12: 659-663.
6. Bourguignon LY, Zhu D, Zhu H, (1998) CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Front Biosci 3: d637-649.
7. Seth A, Gote L, Nagarkatti M, Nagarkatti PS, (1991) T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14. Proc Natl Acad Sci U S A 88: 7877-7881.
8. Rafi A, Nagarkatti M, Nagarkatti PS, (1997) Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 89: 2901-2908.
9. Chen D, McKallip RJ, Zeytun A, Do Y, Lombard C, et al. (2001) CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. J Immunol 166: 5889-5897.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
11. McKallip RJ, Fisher M, Do Y, Szakal AK, Gunthert U, et al. (2003) Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes. J Biol Chem 278: 43818-43830.
12. McKallip RJ, Fisher M, Gunthert U, Szakal AK, Nagarkatti PS, et al. (2005) Role of CD44 and its v7 isoform in staphylococcal enterotoxin B-induced toxic shock: CD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damage. Infect Immun 73: 50-61.
13. Sales KM, Winslet MC, Seifalian AM, (2007) Stem cells and cancer: an overview. Stem Cell Rev 3: 249-255.
14. Marhaba R, Zoller M, (2004) CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211-231.
15. Hill A, McFarlane S, Johnston PG, Waugh DJ, (2006) The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Lett 237: 1-9.
16. Jiang L, Deng J, Zhu X, Zheng J, You Y, et al. (2012) CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res 14: R105.
17. Gotte M, Yip GW, (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66: 10233-10237.
18. Xin Z, Cheng-yi W, (2012) Association of CD44 polymorphisms with chemosensitivity to anthracycline-based chemotherapy in breast cancer. Journal of Jilin University Medicine Edition 38: 110-114.
19. Zhou J, Nagarkatti PS, Zhong Y, Creek K, Zhang J, et al. (2010) Unique SNP in CD44 intron 1 and its role in breast cancer development. Anticancer Res 30: 1263-1272.
20. Edge SB, Compton CC, (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17: 1471-1474.
21. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216.
22. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
23. Miller SA, Dykes DD, Polesky HF, (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
24. Gauderman W (2006) QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies.
25. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, et al. (2006) FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34: W635-641.
26. Lee PH, Shatkay H, (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36: D820-824.
27. So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, et al. (2011) A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Mol Pharmacol 79: 360-367.
28. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, et al. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 89: 12160-12164.
29. Telen MJ, Udani M, Washington MK, Levesque MC, Lloyd E, et al. (1996) A blood group-related polymorphism of CD44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding. J Biol Chem 271: 7147-7153.
30. Lopez JI, Camenisch TD, Stevens MV, Sands BJ, McDonald J, et al. (2005) CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res 65: 6755-6763.
31. Bourguignon LY, (2001) CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia 6: 287-297.
32. Bourguignon LY, Singleton PA, Zhu H, Diedrich F, (2003) Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem 278: 29420-29434.
33. Vazquez A, Grochola LF, Bond EE, Levine AJ, Taubert H, et al. (2010) Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival. Cancer Res 70: 172-180.
34. Winder T, Ning Y, Yang D, Zhang W, Power DG, et al. (2011) Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. Int J Cancer 129: 1096-1104.
35. O'Donnell CJ, Cupples LA, D'Agostino RB, Fox CS, Hoffmann U, et al. (2007) Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study. BMC Med Genet 8Suppl 1: S4.
36. Zhou J, Nagarkatti PS, Zhong Y, Zhang J, Nagarkatti M, (2011) Implications of single nucleotide polymorphisms in CD44 exon 2 for risk of breast cancer. Eur J Cancer Prev 20: 396-402.
37. Bankfalvi A, Terpe HJ, Breukelmann D, Bier B, Rempe D, et al. (1998) Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology 33: 107-116.
38. He-rui Y, ZHI-hua L, Yong-hui L, Feng-xi S (2009) Research of the relationship between CD44 and resistance of breast cancer chemotherapy Chinese Archives of General Surgery 04.